The role of antithrombotic therapy on the patency of peripheral bypasses

被引:5
作者
Bucek, RA
Schnürer, G
Ahmadi, A
Polterauer, P
Kretschmer, G
Minar, E
机构
[1] Univ Vienna, Gen Hosp Vienna, Dept Angiol, A-1090 Vienna, Austria
[2] Univ Vienna, Gen Hosp Vienna, Dept Vasc Surg, A-1090 Vienna, Austria
[3] Univ Vienna, Ludwig Boltzmann Inst Interdisziplinare, Klin Gefassmed Forsch, A-1090 Vienna, Austria
来源
VASA-JOURNAL OF VASCULAR DISEASES | 2000年 / 29卷 / 03期
关键词
anticoagulation; antiplatelet drugs; vascular surgery; peripheral arterial occlusive disease; peripheral bypasses;
D O I
10.1024/0301-1526.29.3.163
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
peripheral bypass surgery is a well-established treatment for symptomatic atherosclerotic disease of the legs. To improve the long-term patency antithrombotic drugs and other adjuvant treatment are applied In this review we summarize the results of randomized studies concerning antithrombotic treatment for prophylaxis after peripheral bypass surgery Heparin is used routinely intra- and perioperatively without strong data, and according to few data low molecular weight heparin may be superior in this situation. Aspirin had positive effects in placebo-controlled studies after infrainguinal PTFE-bypasses, furthermore it is recommended due to its general cardiovascular risk reduction. Ticlopidine improved long-term patency in one randomized study after venous bypass surgery. Otherwise there are some data that long-term oral anticoagulation may be preferable in patients after venous bypass surgery.
引用
收藏
页码:163 / 167
页数:5
相关论文
共 42 条
[1]   COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS [J].
ALTMAN, R ;
CARRERAS, L ;
DIAZ, R ;
FIGUEROA, E ;
PAOLASSO, E ;
PARODI, JC ;
CADE, JF ;
DONNAN, G ;
EADIE, MJ ;
GAVAGHAN, TP ;
OSULLIVAN, EF ;
PARKIN, D ;
RENNY, JTG ;
SILAGY, C ;
VINAZZER, H ;
ZEKERT, F ;
ADRIAENSEN, H ;
BERTRANDHARDY, JM ;
BRAN, M ;
DAVID, JL ;
DRICOT, J ;
LAVENNEPARDONGE, E ;
LIMET, R ;
LOWENTHAL, A ;
MORIAU, M ;
SCHAPIRA, S ;
SMETS, P ;
SYMOENS, J ;
VERHAEGHE, R ;
VERSTRAETE, M ;
ATALLAH, A ;
BARNETT, H ;
BATISTA, R ;
BLAKELY, J ;
CAIRNS, JA ;
COTE, R ;
CROUCH, J ;
EVANS, G ;
FINDLAY, JM ;
GENT, M ;
LANGLOIS, Y ;
LECLERC, J ;
NORRIS, J ;
PINEO, GF ;
POWERS, PJ ;
ROBERTS, R ;
SCHWARTZ, L ;
SICURELLA, J ;
TAYLOR, W ;
THEROUX, P .
BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921) :81-100
[2]   INFLUENCE OF COUMARIN TREATMENT ON PATENCY AND LIMB SALVAGE AFTER PERIPHERAL ARTERIAL RECONSTRUCTIVE SURGERY [J].
ARFVIDSSON, B ;
LUNDGREN, F ;
DROTT, C ;
SCHERSTEN, T ;
LUNDHOLM, K .
AMERICAN JOURNAL OF SURGERY, 1990, 159 (06) :556-560
[3]   Effect of ticlopidine on the long-term patency of saphenous-vein bypass grafts in the legs [J].
Becquemin, JP .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (24) :1726-1731
[4]   Guidelines for the management of patients with valvular heart disease - Executive summary - A report of the American College of Cardiology American Heart Association task force on practice guidelines (committee on management of patients with valvular heart disease) [J].
Bonow, RO ;
Carabello, B ;
de Leon, AC ;
Edmunds, LH ;
Fedderly, BJ ;
Freed, MD ;
Gaasch, WH ;
McKay, CR ;
Nishimura, RA ;
O'Gara, PT ;
O'Rourke, RA ;
Rahimtoola, SH ;
Ritchie, JL ;
Cheitlin, MD ;
Eagle, KA ;
Gardner, TJ ;
Garson, A ;
Gibbons, RJ ;
Russell, RO ;
Ryan, TJ ;
Smith, SC .
CIRCULATION, 1998, 98 (18) :1949-1984
[5]  
CARPENTER JP, 1998, J VASC SURG 0327, P492
[6]   RANDOM CONTROL TRIAL OF A SHORT COURSE OF ASPIRIN AND DIPYRIDAMOLE (PERSANTIN) FOR FEMORODISTAL GRAFTS [J].
CLYNE, CAC ;
ARCHER, TJ ;
ATUHAIRE, LK ;
CHANT, ADB ;
WEBSTER, JHH .
BRITISH JOURNAL OF SURGERY, 1987, 74 (04) :246-248
[7]  
Collaborative overview of randomised trials of antiplatelet therapy-II: maintenance of vascular graft or arterial patency by antiplatelet therapy, 1994, BMJ-BRIT MED J, V308, P159, DOI DOI 10.1136/BMJ.308.6922.159
[8]  
Conte MS, 1998, NEW ENGL J MED, V338, P1387
[9]   THE INFLUENCE OF PLATELET INHIBITION ON THE PATENCY OF FEMORO-POPLITEAL DACRON BYPASS GRAFTS [J].
DONALDSON, DR ;
SALTER, MCP ;
KESTER, RC ;
RAJAH, SM ;
HALL, TJ ;
SREEHARAN, N ;
CROW, MJ .
VASCULAR SURGERY, 1985, 19 (04) :224-230
[10]   LOW-MOLECULAR-WEIGHT HEPARIN VERSUS ASPIRIN AND DIPYRIDAMOLE AFTER FEMOROPOPLITEAL BYPASS-GRAFTING [J].
EDMONDSON, RA ;
COHEN, AT ;
DAS, SK ;
WAGNER, MB ;
KAKKAR, VV .
LANCET, 1994, 344 (8927) :914-918